MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Genetics and phenotypes of recessive parkinsonism in French and North African populations

    S. Lesage, A. Lunati, M. Houot, S. Benromdhan, C. Tesson, F. Clot, C. Mhiri, E. Lohmann, JC. Corvol, A. Brice (Paris, France)

    Objective: To evaluate the mutation frequency in recessive genes and the associated phenotype in a large series of French and North African cases with Parkinson’s…
  • 2019 International Congress

    Acute parkinsonism following an obstructive hydrocephalus and a ventriculoperitoneal shunt revision: a case report

    J. Majuri, HR. Maanpää, A. Kotkansalo, J. Korpela, J. Joutsa (Lahti, Finland)

    Objective: To describe a case of acute parkinsonism following an obstructive hydrocephalus and ventriculoperitoneal (VP) shunt revision. Background: Acute parkinsonism is a rare complication of…
  • 2019 International Congress

    The role of the gut microbial dysbiosis and serum inflammatory profile for the discrimination of clinical subtypes in Parkinson’s disease

    I. Miliukhina, E. Ermolenko, E. Gracheva, A. Istomina, M. Kotyleva, E. Agapova, A. Suvorov (Saint-Petersburg, Russian Federation)

    Objective: To investigate whether clinical phenotypes can be predicted by the assessment of gut microbiome and serum inflammatory profile of PD patients. Background: Recent evidence…
  • 2019 International Congress

    Special features of parkinsonism with congenital anomalies of cerebral vessels

    AS. Norboboev, FAY. Odinaev, GUL. Rakhmatullaeva (Tashkent, Uzbekistan)

    Objective: To study the features of the flow of parkinsonism with congenital anomalies of cerebral vessels. Background: Analysis of the study of neurological status, data…
  • 2019 International Congress

    Liquid Levodopa/Carbidopa – An underutilized, cost effective treatment of advanced Parkinson’s disease in the developing world

    A. Panwar, N. Sawal (Chandigarh, India)

    Objective: Advanced Parkinson’s disease manifests with  “on-off” phenomenon, dyskinesias and increasing symptom severity . Managing it in developing countries is difficult given the low per…
  • 2019 International Congress

    The Progressive Supranuclear Palsy Functional Disability Scale: Sensitivity to change

    I. Piot, K. Schweyer, G. Respondek, M. Grimm, M. Stamelou, P. Sckopke, T. Schenk, C. Goetz, G. Stebbins, G. Höglinger (Munich, Germany)

    Objective: To determine the sensitivity to change within 12 months as well as completion time of the Progressive Supranuclear Palsy Functional Disability Scale (PSPFDS). Background:…
  • 2019 International Congress

    Validation of the Movement Disorder Society criteria for the diagnosis of 4R-tauopathies

    G. Respondek, MJ. Grimm, I. Piot, T. Arzberger, Y. Compta, E. Englund, LW. Ferguson, E. Gelpi, A. Giese, S. Roeber, DJ. Irwin, WG. Meissner, C. Nilsson, A. Pantelyat, A. Rajput, JB. Rowe, JC. van Swieten, C. Troakes, GU. Höglinger (London, United Kingdom)

    Objective: To validate the accuracy of the newly proposed Movement Disorder Society diagnostic criteria for progressive supranuclear palsy (MDS-PSP criteria, Höglinger et al., 2017) to…
  • 2019 International Congress

    Stereopsis as a Visual Biomarker for Parkinson’s Disease

    T. Sang, J. Fatehi, E. Mostofi, B. Zheng, F. Ba (Edmonton, AB, Canada)

    Objective: 1): To assess Parkinson’s disease (PD) patients’ stereopsis function using better and more physiologically meaningful tools; 2): To reveal specific eye behaviors of stereoacuity…
  • 2019 International Congress

    Clinical and imaging characteristics of manifest LRRK2 and GBA carriers: The PPMI cohort

    A. Siderowf, T. Simuni, M. Brumm, L. Uribe, C. Caspell-Garcia, H. Cho, C. Coffey, T. Foroud, B. Mollenhauer, C. Tanner, K. Kieburtz, L. Chahine, D. Weintraub, K. Marek (Chicago, IL, USA)

    Objective: To compare baseline clinical and imaging characteristics of the GBA and LRRK2 PD manifest cohorts to PD sporadic (sPD) cohort. Background: The phenotype and…
  • 2019 International Congress

    Successful treatment of Parkinson’s disease-related impulse control disorder with bilateral STN DBS

    T. Stiep, D. Spengler Shpiner, C. Luca (Miami, FL, USA)

    Objective: To present a case of Parkinson’s disease (PD) complicated by impulse control disorder (ICD) which improved following deep brain stimulation (DBS) targeting the bilateral…
  • « Previous Page
  • 1
  • …
  • 143
  • 144
  • 145
  • 146
  • 147
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley